What is Xeljanz?
Xeljanz (tofacitinib) is an oral prescription medication called a Janus kinase inhibitor used to treat:
- Adults with moderately to severely active rheumatoid arthritis in whom methotrexate did not work well or cannot be tolerated.
- Adults with active psoriatic arthritis in which methotrexate or other similar medicines called nonbiologic disease-modifying antirheumatic drugs (DMARDs) did not work well or cannot be tolerated.
- Adults with moderately to severely active ulcerative colitis when medicines called tumor necrosis factor (TNF) blockers did not work well or cannot be tolerated.
In 2019, the FDA released a safety alert about an increased risk of blood clots and death. If you or a loved one, have suffered any personal injuries after taking Xeljanz or Xeljanz XR, you may be eligible to file a Xeljanz lawsuit.
What is Xeljanz XR
Xeljanz XR is the “extended-release” version of the drug which delays the release of the medicine throughout the day. Xeljanz XR is solely for those who are taking the pill for rheumatoid arthritis and who do not have kidney or liver issues.